Cargando…

NPAS3 variants in schizophrenia: a neuroimaging study

BACKGROUND: This research is a one-site neuroimaging component of a two-site genetic study involving patients with schizophrenia at early and later stages of illness. Studies support a role for the neuronal Per-Arnt-Sim 3 (NPAS3) gene in processes that are essential for normal brain development. Spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernier, Denise, Macintyre, Georgina, Bartha, Robert, Hanstock, Christopher C, McAllindon, David, Cox, Diane, Purdon, Scot, Aitchison, Katherine J, Rusak, Benjamin, Tibbo, Philip G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986669/
https://www.ncbi.nlm.nih.gov/pubmed/24674381
http://dx.doi.org/10.1186/1471-2350-15-37
_version_ 1782311752024719360
author Bernier, Denise
Macintyre, Georgina
Bartha, Robert
Hanstock, Christopher C
McAllindon, David
Cox, Diane
Purdon, Scot
Aitchison, Katherine J
Rusak, Benjamin
Tibbo, Philip G
author_facet Bernier, Denise
Macintyre, Georgina
Bartha, Robert
Hanstock, Christopher C
McAllindon, David
Cox, Diane
Purdon, Scot
Aitchison, Katherine J
Rusak, Benjamin
Tibbo, Philip G
author_sort Bernier, Denise
collection PubMed
description BACKGROUND: This research is a one-site neuroimaging component of a two-site genetic study involving patients with schizophrenia at early and later stages of illness. Studies support a role for the neuronal Per-Arnt-Sim 3 (NPAS3) gene in processes that are essential for normal brain development. Specific NPAS3 variants have been observed at an increased frequency in schizophrenia. In humans, NPAS3 protein was detected in the hippocampus from the first trimester of gestation. In addition, NPAS3 protein levels were reduced in the dorsolateral prefrontal cortex of some patients with schizophrenia. Npas3 knockout mice display behavioural, neuroanatomical and structural changes with associated severe reductions in neural precursor cell proliferation in the hippocampal dentate gyrus. This study will evaluate the hypothesis that the severe reductions in neural precursor cell proliferation in the dentate gyrus will be present to some degree in patients carrying schizophrenia-associated NPAS3 variants and less so in other patients. METHODS/DESIGN: Patients enrolled in the larger genetic study (n = 150) will be invited to participate in this neuroimaging arm. The genetic data will be used to ensure a sample size of 45 participants in each genetic subgroup of patients (with and without NPAS3 variants). In addition, we will recruit 60 healthy controls for acquisition of normative data. The following neuroimaging measures will be acquired from the medial temporal region: a) an index of the microcellular environment; b) a macro-structural volumetric measure of the hippocampus; and c) concentration levels of N-acetylaspartate, a marker of neuronal health. DISCUSSION: This study will help to establish the contribution of the NPAS3 gene and its variants to brain tissue abnormalities in schizophrenia. Given the genetic and phenotypic heterogeneity of the disorder and the large variation in outcomes, the identification of biological subgroups may in future support tailoring of treatment approaches in order to optimize recovery.
format Online
Article
Text
id pubmed-3986669
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39866692014-04-16 NPAS3 variants in schizophrenia: a neuroimaging study Bernier, Denise Macintyre, Georgina Bartha, Robert Hanstock, Christopher C McAllindon, David Cox, Diane Purdon, Scot Aitchison, Katherine J Rusak, Benjamin Tibbo, Philip G BMC Med Genet Study Protocol BACKGROUND: This research is a one-site neuroimaging component of a two-site genetic study involving patients with schizophrenia at early and later stages of illness. Studies support a role for the neuronal Per-Arnt-Sim 3 (NPAS3) gene in processes that are essential for normal brain development. Specific NPAS3 variants have been observed at an increased frequency in schizophrenia. In humans, NPAS3 protein was detected in the hippocampus from the first trimester of gestation. In addition, NPAS3 protein levels were reduced in the dorsolateral prefrontal cortex of some patients with schizophrenia. Npas3 knockout mice display behavioural, neuroanatomical and structural changes with associated severe reductions in neural precursor cell proliferation in the hippocampal dentate gyrus. This study will evaluate the hypothesis that the severe reductions in neural precursor cell proliferation in the dentate gyrus will be present to some degree in patients carrying schizophrenia-associated NPAS3 variants and less so in other patients. METHODS/DESIGN: Patients enrolled in the larger genetic study (n = 150) will be invited to participate in this neuroimaging arm. The genetic data will be used to ensure a sample size of 45 participants in each genetic subgroup of patients (with and without NPAS3 variants). In addition, we will recruit 60 healthy controls for acquisition of normative data. The following neuroimaging measures will be acquired from the medial temporal region: a) an index of the microcellular environment; b) a macro-structural volumetric measure of the hippocampus; and c) concentration levels of N-acetylaspartate, a marker of neuronal health. DISCUSSION: This study will help to establish the contribution of the NPAS3 gene and its variants to brain tissue abnormalities in schizophrenia. Given the genetic and phenotypic heterogeneity of the disorder and the large variation in outcomes, the identification of biological subgroups may in future support tailoring of treatment approaches in order to optimize recovery. BioMed Central 2014-03-27 /pmc/articles/PMC3986669/ /pubmed/24674381 http://dx.doi.org/10.1186/1471-2350-15-37 Text en Copyright © 2014 Bernier et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Bernier, Denise
Macintyre, Georgina
Bartha, Robert
Hanstock, Christopher C
McAllindon, David
Cox, Diane
Purdon, Scot
Aitchison, Katherine J
Rusak, Benjamin
Tibbo, Philip G
NPAS3 variants in schizophrenia: a neuroimaging study
title NPAS3 variants in schizophrenia: a neuroimaging study
title_full NPAS3 variants in schizophrenia: a neuroimaging study
title_fullStr NPAS3 variants in schizophrenia: a neuroimaging study
title_full_unstemmed NPAS3 variants in schizophrenia: a neuroimaging study
title_short NPAS3 variants in schizophrenia: a neuroimaging study
title_sort npas3 variants in schizophrenia: a neuroimaging study
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986669/
https://www.ncbi.nlm.nih.gov/pubmed/24674381
http://dx.doi.org/10.1186/1471-2350-15-37
work_keys_str_mv AT bernierdenise npas3variantsinschizophreniaaneuroimagingstudy
AT macintyregeorgina npas3variantsinschizophreniaaneuroimagingstudy
AT bartharobert npas3variantsinschizophreniaaneuroimagingstudy
AT hanstockchristopherc npas3variantsinschizophreniaaneuroimagingstudy
AT mcallindondavid npas3variantsinschizophreniaaneuroimagingstudy
AT coxdiane npas3variantsinschizophreniaaneuroimagingstudy
AT purdonscot npas3variantsinschizophreniaaneuroimagingstudy
AT aitchisonkatherinej npas3variantsinschizophreniaaneuroimagingstudy
AT rusakbenjamin npas3variantsinschizophreniaaneuroimagingstudy
AT tibbophilipg npas3variantsinschizophreniaaneuroimagingstudy